Inter Ocean Capital Group, LLC Gilead Sciences, Inc. Transaction History
Inter Ocean Capital Group, LLC
- $4.03 Billion
- Q1 2024
A detailed history of Inter Ocean Capital Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Inter Ocean Capital Group, LLC holds 8,179 shares of GILD stock, worth $693,088. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,179
Previous 8,663
5.59%
Holding current value
$693,088
Previous $701,000
14.55%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
1,878Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.77 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.46 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.12 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.03 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $106B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...